IDENTIFICATION OF BONE MORPHOGENETIC PROTEINS AND THEIR RECEPTORS IN HUMAN BREAST CANCER CELL LINES: IMPORTANCE OF BMP2
- 31 December 1999
- Vol. 11 (12) , 1031-1037
- https://doi.org/10.1006/cyto.1999.0508
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Targeted deletion of Smad4 shows it is required for transforming growth factor β and activin signaling in colorectal cancer cellsProceedings of the National Academy of Sciences, 1998
- Bone Morphogenetic Protein and Bone Morphogenetic Protein Gene Family in Bone Formation and RepairClinical Orthopaedics and Related Research, 1998
- Antagonism within and around the organizer: BMP inhibitors in vertebrate body patterningTrends in Genetics, 1997
- Expression of Transforming Growth Factor β (TGFβ) Type III Receptor Restores Autocrine TGFβ1 Activity in Human Breast Cancer MCF-7 CellsPublished by Elsevier ,1997
- Molecular Beacons: Probes that Fluoresce upon HybridizationNature Biotechnology, 1996
- Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cellsThe Prostate, 1994
- Osteolytic bone metastasis in breast cancerBreast Cancer Research and Treatment, 1994
- Novel Regulators of Bone Formation: Molecular Clones and ActivitiesScience, 1988
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987